The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis
The relationship between plasma levels of pyridostigmine to clinical evaluation of muscle power was examined in nine patients with myasthenia gravis during treatment with pyridostigmine in doses of 60 to 1040 mg daily. Five of the nine subjects demonstrated a trend towards a positive correlation, bu...
Salvato in:
| Pubblicato in: | J Neurol Neurosurg Psychiatry |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
1981
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC491235/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7334410/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.12.1141 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|